St. Louis, MO-based Veran Medical closed a $12 million financing round. The company, specializing in thoracic navigation and biopsy for early detection of lung cancer, will use the funds toward continued commercial expansion in the U.S. and international launch of the Veran Thoracic Navigation System. The system aims to offer early detection for lung cancer patients, thereby reducing the number of patients receiving a less treatable late-stage diagnosis. Release